Table 2.
Table depicting pattern of treatment.
| Variable | Value |
|---|---|
| Treatment pattern-No (%) | |
| Best supportive care only | 24 (28.6) |
| Systemic therapy only | 17 (20.2) |
| Intrathecal + systemic therapy | 24 (28.6) |
| Intrathecal only | 9 (10.7) |
| Radiation only | 10 (11.9) |
| Radiation-No (%) | |
| Yes | 18a(21.4) |
| No | 66 (78.6) |
| Radiation type-No (%) | |
| Focal | 15 (17.9) |
| CSI | 3 (3.6) |
| Systemic therapy-No (%) | |
| Targeted | 21 (25) |
| Chemotherapy | 16 (19) |
| Chemotherapy + targeted | 4 (4.8) |
| Type of intrathecal therapy-No (%) | |
| Methotrexate | 23 (27.4) |
| Triple | 10 (11.9) |
| Duration of therapy | |
| Median (Range) | 4 (1–14 weeks) |
Triple–methotrexate, AraC (cytosine arabinoside) and hydrocortisone. CSI- Craniospinal irradiation.
a
In 8 patients it was given along with systemic therapy and in 10 it was administered as the sole therapy.